Cell and Cell-Free Therapies in Osteoarthritis

    November 2021 in “ Biomedicines
    Pau Peláez, E Damia, Marta Torres-Torrillas, Déborah Chicharro, Belén Cuervo, Laura De Miguel, Ayla Del Romero, José M. Carrillo, Joaquín Sopena, Mónica Rubio
    Image of study
    TLDR Some therapies using stem cells and platelet-rich plasma may help treat osteoarthritis, but more research is needed to ensure they are safe and effective.
    The document discusses the potential of cell and cell-free therapies in treating osteoarthritis. It emphasizes the role of mesenchymal stem cells (MSCs) and adipose-derived stem cells (ADSCs) in promoting cartilage regeneration and slowing osteoarthritis progression. The use of platelet-rich plasma (PRP) in knee osteoarthritis treatment is also mentioned. However, the effectiveness of these therapies can be influenced by factors like the donor's age and the stem cells' source. The document also discusses the use of autologous uncultured adipose-derived stromal cells in inhibiting cartilage degeneration. While these therapies show promise, more research is needed to confirm their safety and efficacy.
    Discuss this study in the Community →

    Cited in this study

    5 / 5 results